Owner
U
UntitledVerification
Tags
TERATOGENESIS – DRUGS (COMPLETE NOTE)
Key principles (EXAM FIRST)
- Greatest risk = 3–8 weeks gestation (organogenesis)
- Effect depends on:
- Drug
- Dose
- Timing
- Teratogens cause structural malformations, not just growth issues
- Some drugs cause functional defects even later in pregnancy
MASTER TABLE – TERATOGENIC DRUGS
Drug / Group | Major Fetal Effects | Classic Exam Hook |
Alcohol | • Growth restriction • Microcephaly • Intellectual disability • Facial anomalies (smooth philtrum, thin upper lip, short palpebral fissures) • Cardiac defects (VSD) | Most common preventable cause of intellectual disability |
Isotretinoin (Vitamin A) | • Craniofacial anomalies (cleft lip/palate, microtia) • CNS defects (microcephaly, hydrocephalus) • Conotruncal heart defects • Thymic hypoplasia | Absolutely contraindicated (Category X) |
Thalidomide | • Limb reduction defects (phocomelia) • Ear & eye defects • Cardiac, renal, GI anomalies | Phocomelia = thalidomide |
Valproate | • Neural tube defects (spina bifida) • Facial dysmorphism • Developmental delay | Highest NTD risk among AEDs |
Carbamazepine | • Neural tube defects (lower than valproate) | AED → think NTD |
Phenytoin | • Fetal hydantoin syndrome • Craniofacial anomalies • Hypoplastic nails, growth restriction | Anticonvulsant facial pattern |
ACE inhibitors / ARBs | • Renal agenesis/dysgenesis • Oligohydramnios • Pulmonary hypoplasia • Skull hypoplasia | 2nd–3rd trimester renal failure |
Warfarin | • Nasal hypoplasia • Stippled epiphyses (chondrodysplasia punctata) • CNS hemorrhage | Warfarin embryopathy |
Lithium | • Ebstein anomaly | Lithium → Tricuspid valve |
Methotrexate | • Craniofacial anomalies • Limb defects • Growth restriction | Folate antagonist |
Tetracyclines | • Tooth discoloration • Enamel hypoplasia • Bone growth inhibition | Yellow-brown teeth |
Aminoglycosides | • Ototoxicity (VIII nerve damage) | Sensorineural deafness |
Sulfonamides | • Kernicterus (near term) | Displace bilirubin |
NSAIDs (late pregnancy) | • Premature closure of ductus arteriosus | Avoid in 3rd trimester |
Diethylstilbestrol (DES) | • Clear cell adenocarcinoma of vagina • T-shaped uterus | Young woman + vaginal cancer |
Androgens | • Virilization of female fetus | Ambiguous genitalia |
Misoprostol | • Limb defects • Cranial nerve palsies | Failed abortion attempts |
Cocaine | • Placental abruption • Growth restriction | Vasoconstriction |
ULTRA-HIGH-YIELD PAIRINGS (EXAM RAPID FIRE)
Defect | Drug |
Craniofacial anomalies | Isotretinoin |
Limb reduction (phocomelia) | Thalidomide |
Neural tube defects | Valproate > Carbamazepine |
Renal agenesis | ACE inhibitors / ARBs |
Ebstein anomaly | Lithium |
Tooth discoloration | Tetracyclines |
Stippled epiphyses | Warfarin |
Deafness | Aminoglycosides / Rubella |
Intellectual disability | Alcohol |
EXAM STRATEGY
- If question mentions POA 4–8 weeks → think structural defects
- If renal + oligohydramnios → ACE inhibitors
- If limb absent → thalidomide
- If NTD + epilepsy → valproate
- If acne drug + pregnancy → isotretinoin
ONE-LINE EXAM LOCK
“Isotretinoin → face & heart; Thalidomide → limbs; Valproate → neural tube; ACE inhibitors → kidneys; Warfarin → cartilage.”